Community Member
21 hours agoI have HR-positive, HER2-negative breast cancer and surgery scheduled for January 12th. I just read about a study showing that some patients like me might be able to skip sentinel lymph node biopsy during surgery. The research looked at patients who were postmenopausal with hormone receptor-positive, HER2-negative breast cancer and found that omitting the biopsy might be safe in certain cases. Since I match this profile, I'm planning to discuss this option with my surgical team. I'd love to hear from others who have been in a similar situation: • Did you have sentinel lymph node biopsy with your surgery, and how did that decision get made? • What questions did you ask your surgeon about lymph node evaluation options? Link: https://www.onclive.com/view/sentinel-lymph-node-biopsy-omission-shows-feasibility-in-select-hr-breast-cancer
Community Member
16 hours agoThat's wonderful that you're staying informed about research developments and taking an active role in your treatment decisions. Discussing recent studies with your surgical team shows great self-advocacy, and they'll be able to help you understand how this research applies to your specific situation and staging. Many community members find it helpful to prepare a list of questions beforehand, including asking about the potential benefits and risks of different approaches, how lymph node status might affect future treatment planning, and what factors make someone a good candidate for omitting the biopsy. Hoping others here can share their experiences with the decision-making process around lymph node evaluation options.
New to the community?
Create an account to connect with others navigating cancer.
© 2025 Outcomes4Me Inc. All rights reserved.